BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

623 related articles for article (PubMed ID: 32769150)

  • 21. Rheumatologic Manifestations of Post SARS-CoV-2 Infection: A Case Series.
    Metyas S; Chen C; Aung T; Ballester A; Cheav S
    Curr Rheumatol Rev; 2022; 18(4):346-351. PubMed ID: 35152867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs.
    Michelena X; Borrell H; López-Corbeto M; López-Lasanta M; Moreno E; Pascual-Pastor M; Erra A; Serrat M; Espartal E; Antón S; Añez GA; Caparrós-Ruiz R; Pluma A; Trallero-Araguás E; Barceló-Bru M; Almirall M; De Agustín JJ; Lladós J; Julià A; Marsal S
    Semin Arthritis Rheum; 2020 Aug; 50(4):564-570. PubMed ID: 32425260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence of infection other than tuberculosis in patients with autoimmune rheumatic diseases treated with bDMARDs: a real-time clinical experience from India.
    Chandrashekara S; Shobha V; Rao V; Desai A; Jois R; Dharmanand BG; Kumar S; Kumar P; Dharmapalaiah C; Mahendranath KM; Prasad S; Daware MA; Singh Y; Karjigi U; Nagaraj S; Anupama KR
    Rheumatol Int; 2019 Mar; 39(3):497-507. PubMed ID: 30684040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial.
    Saiz-Rodríguez M; Peña T; Lázaro L; González Á; Martínez A; Cordero JA; Vicente JT; Richard F; Coma MJ; de Frutos M; Labrador J; Pueyo A
    Trials; 2020 Jul; 21(1):632. PubMed ID: 32646502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe COVID-19 in patients with immune-mediated rheumatic diseases: A stratified analysis from the SORCOM multicentre registry.
    Boteanu A; Leon L; Pérez Esteban S; Rabadán Rubio E; Pavía Pascual M; Bonilla G; Bonilla González-Laganá C; García Fernandez A; Recuero Diaz S; Ruiz Gutierrez L; Sanmartín Martínez JJ; de la Torre-Rubio N; Nuño L; Sánchez Pernaute O; Del Bosque I; Lojo Oliveira L; Rodríguez Heredia JM; Clemente D; Abasolo L; Bachiller-Corral J
    Mod Rheumatol; 2023 Dec; 34(1):97-105. PubMed ID: 36516217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics, complications and outcomes among 1549 patients hospitalised with COVID-19 in a secondary hospital in Madrid, Spain: a retrospective case series study.
    Jiménez E; Fontán-Vela M; Valencia J; Fernandez-Jimenez I; Álvaro-Alonso EA; Izquierdo-García E; Lazaro Cebas A; Gallego Ruiz-Elvira E; Troya J; Tebar-Martinez AJ; Garcia-Marina B; Peña-Lillo G; Abad-Motos A; Macaya L; Ryan P; Pérez-Butragueño M; ;
    BMJ Open; 2020 Nov; 10(11):e042398. PubMed ID: 33172949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US 'hot spot'.
    D'Silva KM; Serling-Boyd N; Wallwork R; Hsu T; Fu X; Gravallese EM; Choi HK; Sparks JA; Wallace ZS
    Ann Rheum Dis; 2020 Sep; 79(9):1156-1162. PubMed ID: 32457048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients.
    Zen M; Fuzzi E; Astorri D; Saccon F; Padoan R; Ienna L; Cozzi G; Depascale R; Zanatta E; Gasparotto M; Benvenuti F; Bindoli S; Gatto M; Felicetti M; Ortolan A; Campaniello D; Larosa M; Lorenzin M; Ramonda R; Sfriso P; Schiavon F; Iaccarino L; Doria A
    J Autoimmun; 2020 Aug; 112():102502. PubMed ID: 32527675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rheumatologists' perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets.
    Misra DP; Agarwal V; Gasparyan AY; Zimba O
    Clin Rheumatol; 2020 Jul; 39(7):2055-2062. PubMed ID: 32277367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature review.
    Bakasis AD; Mavragani CP; Boki KA; Tzioufas AG; Vlachoyiannopoulos PG; Stergiou IE; Skopouli FN; Moutsopoulos HM
    J Autoimmun; 2021 Sep; 123():102687. PubMed ID: 34311142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurological complications in a predominantly African American sample of COVID-19 predict worse outcomes during hospitalization.
    Chachkhiani D; Soliman MY; Barua D; Isakadze M; Villemarette-Pittman NR; Devier DJ; Lovera JF
    Clin Neurol Neurosurg; 2020 Oct; 197():106173. PubMed ID: 32877769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.
    Grasselli G; Greco M; Zanella A; Albano G; Antonelli M; Bellani G; Bonanomi E; Cabrini L; Carlesso E; Castelli G; Cattaneo S; Cereda D; Colombo S; Coluccello A; Crescini G; Forastieri Molinari A; Foti G; Fumagalli R; Iotti GA; Langer T; Latronico N; Lorini FL; Mojoli F; Natalini G; Pessina CM; Ranieri VM; Rech R; Scudeller L; Rosano A; Storti E; Thompson BT; Tirani M; Villani PG; Pesenti A; Cecconi M;
    JAMA Intern Med; 2020 Oct; 180(10):1345-1355. PubMed ID: 32667669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient characteristics, clinical course and factors associated to ICU mortality in critically ill patients infected with SARS-CoV-2 in Spain: A prospective, cohort, multicentre study.
    Ferrando C; Mellado-Artigas R; Gea A; Arruti E; Aldecoa C; Bordell A; Adalia R; Zattera L; Ramasco F; Monedero P; Maseda E; Martínez A; Tamayo G; Mercadal J; Muñoz G; Jacas A; Ángeles G; Castro P; Hernández-Tejero M; Fernandez J; Gómez-Rojo M; Candela Á; Ripollés J; Nieto A; Bassas E; Deiros C; Margarit A; Redondo FJ; Martín A; García N; Casas P; Morcillo C; Hernández-Sanz ML;
    Rev Esp Anestesiol Reanim (Engl Ed); 2020 Oct; 67(8):425-437. PubMed ID: 32800622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biologic treatment for rheumatic disease: real-world big data analysis from the Greek country-wide prescription database.
    Sfikakis PP; Bournia VK; Sidiropoulos P; Boumpas DT; Drosos AA; Kitas GD; Konstantonis G; Liossis SN; Manoussakis MN; Sakkas L; Tektonidou M; Tzioufas AG; Vlachoyiannopoulos PG; Kani C; Paterakis P; Litsa P; Vassilopoulos D
    Clin Exp Rheumatol; 2017; 35(4):579-585. PubMed ID: 28281458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19 in rheumatic disease patients on immunosuppressive agents.
    Sharmeen S; Elghawy A; Zarlasht F; Yao Q
    Semin Arthritis Rheum; 2020 Aug; 50(4):680-686. PubMed ID: 32512263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases.
    Gottenberg JE; Guillevin L; Lambotte O; Combe B; Allanore Y; Cantagrel A; Larroche C; Soubrier M; Bouillet L; Dougados M; Fain O; Farge D; Kyndt X; Lortholary O; Masson C; Moura B; Remy P; Thomas T; Wendling D; Anaya JM; Sibilia J; Mariette X;
    Ann Rheum Dis; 2005 Jun; 64(6):913-20. PubMed ID: 15550531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correspondence on 'Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases'.
    Aydin SZ; Hepworth E; Tugwell P
    Ann Rheum Dis; 2023 Mar; 82(3):e69. PubMed ID: 33355117
    [No Abstract]   [Full Text] [Related]  

  • 38. Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of follow-up: A retrospective cohort study.
    Moreno-Pérez O; Andres M; Leon-Ramirez JM; Sánchez-Payá J; Rodríguez JC; Sánchez R; García-Sevila R; Boix V; Gil J; Merino E
    J Autoimmun; 2020 Nov; 114():102523. PubMed ID: 32690352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retrospective analysis of high flow nasal therapy in COVID-19-related moderate-to-severe hypoxaemic respiratory failure.
    Patel M; Gangemi A; Marron R; Chowdhury J; Yousef I; Zheng M; Mills N; Tragesser L; Giurintano J; Gupta R; Gordon M; Rali P; D'Alonso G; Fleece D; Zhao H; Patlakh N; Criner G
    BMJ Open Respir Res; 2020 Aug; 7(1):. PubMed ID: 32847947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The risk of lymphoma development in autoimmune diseases: a meta-analysis.
    Zintzaras E; Voulgarelis M; Moutsopoulos HM
    Arch Intern Med; 2005 Nov; 165(20):2337-44. PubMed ID: 16287762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.